Preview

Pacific Medical Journal

Advanced search

Diagnostic and prognostic informativity of new lectin immunoenzymometric method for diagnosing cervical cancer

Abstract

Based upon 120 case follow-ups, the authors estimate efficiency of applying lectin immunoenzymometric method intended for differential diagnostics of benign and malignant neoplasms of uterine cervix, and analyze contents of lectin-related embryonic cancer and embryo-like cancer antigens in vaginal secretion. With this end in view, the authors use mannan-binding lectin of the Far-eastern sea cucumber Apostichopus japonicus to identify statistically reliable differences between the levels of lectin-binding antigens between healthy women and patients with cervical cancer, and between patients with benign and malignant neoplasms. The method sensitivity and specificity are 93.6 and 87.8%, respectively, given the cut-off level of 12.74 ng/ml. With all this in view, this method has more advantages compared to those associated with determining of concentration of embryonic cancer antigen and squamous cell carcinoma antigen in blood serum.

About the Authors

A. A. Bulgakov
Pacific Institute of Bioorganic Chemistry, FEB RAS
Russian Federation


O. M. Rodionova
Out-Patient Clinic No. 8, Vladivostok
Russian Federation


I. Yu. Petrova
Institute of Marine Biology, FEB RAS
Russian Federation


M. G. Eliseikina
Institute of Marine Biology, FEB RAS
Russian Federation


A. Yu. Rodionov
Far Eastern Technical University
Russian Federation


V. I. Apanasevich
Vladivostok State Medical University
Russian Federation


References

1. Булгаков А.А., Родионова О.М., Петрова И.Ю и др. Применение лектин-иммуноферментного метода в диагностике рака шейки матки // Системный анализ и управление в биомедицинских исследованиях. 2006. Т. 5, № 4. С. 792-796.

2. Bulgakov A.A., Eliseikina M.G., Petrova I.Yu. et al. Molecular and biological characterization of a mannan-binding lectin from the holothurian Apostichopus japonicus // Glycobiology. 2007. Vol. 17, No. 12. P. 1284-1298.

3. Gloria B. Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix // Gynecol. Oncology. 1995. Vol. 57, No. 2. P. 205-211.

4. Gaarenstroom K.N., Kenter G.G., Bonfrer J.M.G. et al. Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis // Gynecol. Oncol. 2000. Vol. 77. P. 164-170.

5. Gadducci A., Tana R., Cosio S. et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer // Critical Reviev in Oncology/Hematology. 2008. Vol. 66, No. 1. P. 10-20.

6. Scambia G., Benedetti Panici P., Foti E. et al. Multiple tumour marker assays in advanced cervical cancer: relationship to chemotherapy response and clinical outcome // Eur. J. of Cancer. 1996. Vol. 32, No. 2. P. 259-263.


Review

For citations:


Bulgakov A.A., Rodionova O.M., Petrova I.Yu., Eliseikina M.G., Rodionov A.Yu., Apanasevich V.I. Diagnostic and prognostic informativity of new lectin immunoenzymometric method for diagnosing cervical cancer. Pacific Medical Journal. 2011;(1):96-97. (In Russ.)

Views: 238


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)